Vedana Therapeutics
Develops next-generation therapies for migraine prevention
$46MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Develops next-generation therapies for migraine prevention
Develops first- and best-in-class antibody-drug conjugates (ADCs) for cancer treatment
Pitching Dawn Biopharma? Send the deck from a free RoundOS data room and see which pages they read.